Today, the Solana (SOL) market performed brightly, with a price rise of 4%, reaching 168 USD. This increase not only reflects the overall market recovery but also highlights institutional investors' confidence in Solana.

It is worth noting that Artelo Biosciences, a company in the biotech field, has become the first pharmaceutical company to make a large-scale investment in Solana, with an investment amount of nearly $9.5 million. This move may attract more biotech companies to pay attention to diversified investments in digital assets, bringing more support to Solana.

From a technical analysis perspective, Solana's performance is equally encouraging. The price rebounded from the lower Bollinger Band at $156.83, and the MACD indicator has released a buy signal, suggesting that the upward trend may continue. Supported by trading volume, $180 has become the next key resistance level. If successfully broken, it may further test $185 or even $190.

Meanwhile, the Solana ecosystem is continuously expanding. Its first Layer 2 network project, Solaxy, is about to launch on the mainnet, with an expected staking annual yield of up to 70%. This development greatly enhances Solana's competitiveness in terms of scalability.

Overall, whether it is institutional investment, technical analysis, or ecosystem development, Solana shows strong momentum for growth. These factors collectively drive Solana to become one of the projects worth closely watching in the cryptocurrency market. However, investors still need to be cautious, closely monitor market changes, and make informed investment decisions.